These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29620612)

  • 1. Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.
    Rovira J; Ramírez-Bajo MJ; Banon-Maneus E; Lazo-Rodríguez M; Moya-Rull D; Hierro-Garcia N; Tubita V; Piñeiro GJ; Revuelta I; Ventura-Aguiar P; Cucchiari D; Oppenheimer F; Brunet M; Campistol JM; Diekmann F
    Transplantation; 2018 Jul; 102(7):1075-1084. PubMed ID: 29620612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages contribute to cellular but not humoral mechanisms of acute rejection in rat renal allografts.
    Ma FY; Woodman N; Mulley WR; Kanellis J; Nikolic-Paterson DJ
    Transplantation; 2013 Dec; 96(11):949-57. PubMed ID: 24056626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.
    Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C
    Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tofacitinib in kidney transplantation.
    Wojciechowski D; Vincenti F
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1193-9. PubMed ID: 23841583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting JAK3 in kidney transplantation: current status and future options.
    Wojciechowski D; Vincenti F
    Curr Opin Organ Transplant; 2011 Dec; 16(6):614-9. PubMed ID: 21971513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting JAK/STAT Signaling to Prevent Rejection After Kidney Transplantation: A Reappraisal.
    Baan CC; Kannegieter NM; Felipe CR; Tedesco Silva H
    Transplantation; 2016 Sep; 100(9):1833-9. PubMed ID: 27163538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy.
    Yang L; Lu YP; Luo GH; Song J; Tu ZD; Li YP
    Transplant Proc; 2008 Oct; 40(8):2786-9. PubMed ID: 18929862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
    Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
    Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of C4d staining as a humoral injury marker.
    Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
    Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Li J; Basler M; Alvarez G; Brunner T; Kirk CJ; Groettrup M
    Kidney Int; 2018 Mar; 93(3):670-680. PubMed ID: 29229189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Spleen Tyrosine Kinase Reduces Renal Allograft Injury in a Rat Model of Acute Antibody-Mediated Rejection in Sensitized Recipients.
    Ramessur Chandran S; Han Y; Tesch GH; Di Paolo J; Mulley WR; Kanellis J; Ma FY; Nikolic-Paterson DJ
    Transplantation; 2017 Aug; 101(8):e240-e248. PubMed ID: 28594748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection.
    Koch M; Poehnert D; Nashan B
    Transpl Immunol; 2016 Mar; 35():12-7. PubMed ID: 26802360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Model of Acute Antibody-Mediated Renal Allograft Rejection in the Sensitized Rata.
    Chandran SR; Mulley WR; Kanellis J; Nikolic-Paterson DJ; Ma FY
    Exp Clin Transplant; 2018 Jun; 16(3):294-300. PubMed ID: 28760115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies.
    Halloran PF; Reeve JP; Pereira AB; Hidalgo LG; Famulski KS
    Kidney Int; 2014 Feb; 85(2):258-64. PubMed ID: 23965521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation model.
    Nakamura K; Kawato Y; Kaneko Y; Hanaoka K; Kubo K; Nakanishi T; Maeda M; Fukahori H; Ito M; Noto T; Inami M; Hirose J; Morokata T
    Transpl Immunol; 2018 Feb; 46():14-20. PubMed ID: 28988984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    Deuse T; Hua X; Taylor V; Stubbendorff M; Baluom M; Chen Y; Park G; Velden J; Streichert T; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2012 Oct; 94(7):695-702. PubMed ID: 22971540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of JAK3 and PKC via Immunosuppressive Drugs Tofacitinib and Sotrastaurin Inhibits Proliferation of Human B Lymphocytes In Vitro.
    Martina MN; Ramirez Bajo MJ; Bañon-Maneus E; Moya Rull D; Hierro-Garcia N; Revuelta I; Campistol JM; Rovira J; Diekmann F
    Transplant Proc; 2016 Nov; 48(9):3046-3052. PubMed ID: 27932144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of late antibody-mediated rejection (C4d-mediated rejection): a single-center experience.
    Tatar E; Uslu A; Simsek C; Vardar E
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():259-62. PubMed ID: 25894167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis.
    Wei X; Wu J; Zhao G; Galdamez J; Lele SM; Wang X; Liu Y; Soni DM; Purdue PE; Mikuls TR; Goldring SR; Wang D
    Mol Pharm; 2018 Aug; 15(8):3456-3467. PubMed ID: 29966420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Complex-Type Deposits in the Fischer-344 to Lewis Rat Model of Renal Transplantation and a Subset of Human Transplant Glomerulopathy.
    Grau V; Zeuschner P; Immenschuh S; Bockmeyer CL; Zell S; Wittig J; Säuberlich K; Abbas M; Padberg W; Meyer-Schwesinger C; von Brandenstein M; Schlosser M; Dieplinger G; Galliford J; Clarke C; Roufosse C; Becker JU
    Transplantation; 2016 May; 100(5):1004-14. PubMed ID: 26895216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.